VYNE
VYNE THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
VYNE THERAPEUTICS INC (VYNE) is held as common stock by 2 tracked hedge-fund managers, with a combined reported value of ~$320.0K; the largest are Ken Griffin, Renaissance Technologies. This quarter: 1 added, 1 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · LowThis quarter · Quiet
Common-stock holders2
Congress trades0
Price$28.56vs quarter-end+4289.12%
Sectors0
This quarter's moves
Top holderNew0
Added1
Trimmed / sold1
Ken GriffinCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.